A searchable database of
medically documented cases

About the Project

Spontaneous Regression Of Cutaneous Metastases Of Squamous Cell Carcinoma

Foley, C., Moran, B., McMenamin, M., McDermott, R., Or monthsd, P., & Irvine, A. D. (2014). spontaneous regression of cutaneous metastases of squamous cell carcinoma. QJM : monthsly journal of the Association of Physicians, 107(1), 61–63. https://doi.org/10.1093/qjmed/hct162

View Original Source →

Abstract

### Learning Point for Clinicians Metastatic cutaneous squamous cell carcinoma has a poor prognosis and spontaneous regression is exceptionally rare. These patients should be managed within a skin cancer multidisciplinary team and informed of all possible management options. A previously healthy 74-year-old lady was referred to our dermatology department with a rash on her right leg for 3 months. Multiple discrete dermal and subcutaneous nodules were distributed circumferentially on the skin between the knee and the ankle on the right leg (Figure 1a). Figure 1. (a) Clinical photography of right leg at presentation showing multiple subcutaneous metastatic deposits. (b) 18F FDG PET-CT images of right leg at presentation demonstrating multiple foci of abnormal increased 18F FDG accumulation. (c) Clinical photography of right leg showing resolution of metastatic deposits 6 months later. (d) 18F FDG PET-CT images of right leg 6 months after presentation demonstrating radiological regression of the lesions. A biopsy of one of these nodules showed intact epidermis with underlying poorly differentiated acantholytic …

Case Details

Disease Location

Right lower extremity between knee and ankle

Personal Characteristics

74 -year-old female

Clinical Characteristics

3 months history of right leg rash with multiple nodules involving dermis and subcutaneous tissues. Biopsy(+) squamous cell cancer, PET and exam negative for primary or metastatic disease beyond the leg.

Remission Characteristics

Partial regression in number and size of ndules at 12 weeks total regression at 20 weeks maintained at last follow up at 18 months

Treatment & Mechanisms

Proposed Remission Mechanisms

Immunology, hormonal or psychological factors